4//SEC Filing
Kirpekar Sahil 4
Accession 0000899243-23-008775
CIK 0001840904other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 8:20 PM ET
Size
7.8 KB
Accession
0000899243-23-008775
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Award
Stock Option
2023-03-14+275,000→ 275,000 totalExercise: $1.18Exp: 2033-03-14→ Common Shares (275,000 underlying) - Award
Restricted Stock Unit
2023-03-14+200,000→ 200,000 total→ Common Shares (200,000 underlying)
Footnotes (2)
- [F1]The stock option shall vest as to 25% of the underlying shares on March 14, 2024, and in 36 substantially equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001951712
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 8:20 PM ET
- Size
- 7.8 KB